These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16540655)

  • 1. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
    Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
    Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells.
    Khatib AM; Kontogiannea M; Fallavollita L; Jamison B; Meterissian S; Brodt P
    Cancer Res; 1999 Mar; 59(6):1356-61. PubMed ID: 10096570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.
    Khatib AM; Fallavollita L; Wancewicz EV; Monia BP; Brodt P
    Cancer Res; 2002 Oct; 62(19):5393-8. PubMed ID: 12359742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
    Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
    Kitakata H; Nemoto-Sasaki Y; Takahashi Y; Kondo T; Mai M; Mukaida N
    Cancer Res; 2002 Nov; 62(22):6682-7. PubMed ID: 12438267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tumorigenicity and metastatic potential in carcinoma cells expressing the extracellular domain of the type 1 insulin-like growth factor receptor.
    Samani AA; Chevet E; Fallavollita L; Galipeau J; Brodt P
    Cancer Res; 2004 May; 64(10):3380-5. PubMed ID: 15150088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes involved in innate responsiveness to bacterial products by differential display.
    Jin F; Nathan C; Ding A
    Methods; 1998 Dec; 16(4):396-406. PubMed ID: 10049647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver.
    Long L; Nip J; Brodt P
    Cancer Res; 1994 Jul; 54(14):3732-7. PubMed ID: 7518344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis.
    Khatib AM; Auguste P; Fallavollita L; Wang N; Samani A; Kontogiannea M; Meterissian S; Brodt P
    Am J Pathol; 2005 Sep; 167(3):749-59. PubMed ID: 16127154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor in cancer development.
    Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
    Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
    Long L; Rubin R; Baserga R; Brodt P
    Cancer Res; 1995 Mar; 55(5):1006-9. PubMed ID: 7866982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
    Nakamura K; Takamoto N; Hongo A; Kodama J; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
    Oncol Rep; 2008 May; 19(5):1085-91. PubMed ID: 18425362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor.
    Long L; Rubin R; Brodt P
    Exp Cell Res; 1998 Jan; 238(1):116-21. PubMed ID: 9457063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
    Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
    J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
    Wang X; Li X; Xu L; Zhan Y; Yaish-Ohad S; Erhardt JA; Barone FC; Feuerstein GZ
    Mol Pharmacol; 2003 Oct; 64(4):833-40. PubMed ID: 14500739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of TNF-alpha-induced E-selectin expression in endothelial cells via the JNK/NF-kappaB pathways by highly N-acetylated chitooligosaccharides.
    Lin CW; Chen LJ; Lee PL; Lee CI; Lin JC; Chiu JJ
    Biomaterials; 2007 Mar; 28(7):1355-66. PubMed ID: 17126899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
    Ashcroft GS; Lei K; Jin W; Longenecker G; Kulkarni AB; Greenwell-Wild T; Hale-Donze H; McGrady G; Song XY; Wahl SM
    Nat Med; 2000 Oct; 6(10):1147-53. PubMed ID: 11017147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.